Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (20)

2024

  1. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131

  3. Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score

    Neurology, Vol. 98, Núm. 5, pp. E518-E532

  4. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  5. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

    European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091

  2. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  3. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  4. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2020

  1. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

2019

  1. Genome-wide association study of white blood cell counts in patients with ischemic stroke

    Stroke, Vol. 50, Núm. 12, pp. 3618-3621

  2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585

2018

  1. Regional variation of Guillain-Barré syndrome

    Brain, Vol. 141, Núm. 10, pp. 2866-2877

2017

  1. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

    Journal of the Peripheral Nervous System, Vol. 22, Núm. 2, pp. 68-76

2016

  1. The H-ATOMIC criteria for the etiologic classification of patients with intracerebral hemorrhage

    PLoS ONE, Vol. 11, Núm. 6

2015

  1. Myasthenia gravis: Descriptive analysis of life-threatening events in a recent nationwide registry

    European Journal of Neurology, Vol. 22, Núm. 7, pp. 1056-1061

2013

  1. Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide

    Human Mutation, Vol. 34, Núm. 1, pp. 79-82

  2. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study.

    Muscle & nerve, Vol. 48, Núm. 6, pp. 870-876

2012

  1. Guía clínica de la enfermedad de pompe de inicio tardío

    Revista de Neurologia, Vol. 54, Núm. 8, pp. 497-507